SomaLogic, Inc. (NASDAQ:SLGC) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET

Company Participants

Marissa Bych - Investor Relations, Gilmartin Group LLC

Adam Taich - Chief Executive Officer

Shaun Blakeman - Chief Financial Officer

Conference Call Participants

Daniel Brennan - TD Cowen

Dan Arias - Stifel Financial Corp.

Kyle Mikson - Canaccord Genuity Group Inc.

Brandon Couillard - Jefferies Group LLC

Operator

Good afternoon, and welcome to SomaLogic’s First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today’s call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Marissa Bych with Gilmartin Group Investor Relations for introductory comments.

Marissa Bych

Thank you. Today, SomaLogic released financial results for the quarter ended March 31, 2023. A copy of the press release is available on the company’s website. Before we begin, I’d like to remind you that management will make forward-looking statements during this call within the meaning of federal securities laws, which are made pursuant to the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that relates to expectations or predictions of future events, results or performance are forward-looking statements. All forward-looking statements, including without limitation, those relating to our market opportunity, gross margin and future financial performance, protein content and database growth, customer base, diagnostic pipeline, expectations for hiring, and growth in our organization are based upon our current estimates and various assumptions.

These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our latest Form 10-K or 10-Q filed with the Securities and Exchange Commission.

This conference call contains time-sensitive information and is actuate only as of the live broadcast today, May 11, 2023. SomaLogic disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise.

I will now turn the call over to Adam Taich, Interim Chief Executive Officer.

Adam Taich